We Learn Cancer’s Design
Sensei Biotherapeutics follows the immune system’s teachings to discover new treatments that inspire the body to fight cancer. The foundational lesson: the properties of the tumor microenvironment create an opportunity to develop highly selective therapeutics against challenging immuno-oncology targets.
We’ve built a pipeline of investigational therapies that are designed to work selectively in the tumor microenvironment. These conditionally active antibodies are expected to unlock previously undruggable targets and may offer new treatment options for cancer patients.
